Healthcare Industry News:  hyperlipidemia 

Biopharmaceuticals Personnel

 News Release - October 3, 2013

Daiichi Sankyo, Inc. Makes Two New Executive Appointments

PARSIPPANY, N.J., Oct. 3, 2013 -- (Healthcare Sales & Marketing Network) -- Daiichi Sankyo, Inc. today announced that Glenn Gormley, MD, PhD, has been named corporate President and Chairman of Daiichi Sankyo, Inc. Dr. Gormley will also continue in his existing roles as President, Daiichi Sankyo Pharma Development, Global Head of Research and Development and Senior Executive Officer of Daiichi Sankyo, Co. Ltd. In addition, Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo, Inc. in the U.S. Both appointments are effective as of October 3, 2013.

Daiichi Sankyo, Inc.'s former President and CEO, and head of its Commercial Division, John Gargiulo, has left the company effective October 3, 2013.

Greg Barrett will hold the new title of Acting President, Daiichi Sankyo Administrative & Commercial Operations. In this role, Mr. Barrett will be responsible for leading the Daiichi Sankyo U.S. Commercial Division including marketing, sales and supply chain operations in the U.S. organization. Mr. Barrett most recently held the position of Vice President, Marketing and Managed Markets, at Daiichi Sankyo, Inc. and has been with the company since the late 1990's.

About Daiichi Sankyo

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit: www.daiichisankyo.com.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is a member of the Daiichi Sankyo Group. For more information on Daiichi Sankyo, Inc., please visit www.dsi.com.


Source: Daiichi Sankyo

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.